TEHRAN (ANA)- Researchers discovered that a protein called the J chain, which helps the immune system function properly, originally came from a different family of genes known as CXCL chemokines.

TEHRAN (ANA)- A senior Iranian official announced that the country is standing among the first 12 countries of the world which have had the highest number of scientific articles in the field of biotechnology.

TEHRAN (ANA)- An Iranian researcher and his teammates at the University of Tehran are working on producing a synthetic fuel in a laboratory environment with the least pollution level through a simulator and combining percentages of materials together.

TEHRAN (ANA)- Iranian researchers succeeded in designing and building a Quantitative Phase Imaging (QPI) microscope which provides both quantitative and beautiful images of living cells.

TEHRAN (ANA)- Iranian researchers at a knowledge-based company succeeded in making a kit which extracts DNA from saliva and enjoys a stabilizer solution to prolong the saliva’s stability for high-quality DNA.

TEHRAN (ANA)- Research from Weill Cornell Medicine reveals that astrocyte receptors impact cognitive functions differently in males and females, suggesting a need for sex-specific approaches in developing treatments targeting these brain cells.

TEHRAN (ANA)- An Iranian student at Islamic Azad University’s Sahr-e Kord branch succeeded in making new biological products by using innovative methods in bioinformatics.

TEHRAN (ANA)- Columbia University’s research has uncovered a longstanding error in identifying gut stem cells, finding the true stem cells in a different site, which could revolutionize regenerative medicine by applying these findings to other organs.

TEHRAN (ANA)- Researchers have produced a first-of-its-kind catalog of gene-isoform variation in the developing human brain and this novel dataset provides crucial insights into the molecular basis of neurodevelopmental and psychiatric brain disorders and paves the way for targeted therapies.

TEHRAN (ANA)- Scientists at the Francis Crick Institute identified a key biological pathway in IBD involving the ETS2 protein, which can be targeted with already available MEK inhibitor drugs to potentially reduce disease symptoms.